This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Japan Science and Technology Agency. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yasuhito Tokumoto: Innovator in Oligodendrocyte Progenitor Cell Production
Introduction
Yasuhito Tokumoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cellular biology, particularly in the production of oligodendrocyte progenitor cells. His innovative methods have the potential to advance therapeutic applications in neurobiology.
Latest Patents
Yasuhito Tokumoto holds a patent for an "Adult oligodendrocyte-type 2 astrocyte progenitor cell production method." This invention provides a method for producing adult oligodendrocyte progenitor cells from proliferative oligodendrocyte progenitor cells. The method is characterized by inducing proliferating OPC to differentiate into adult OPC by culturing in the presence of a ligand of a thyroid hormone receptor or retinoic acid receptor in a low oxygen environment. The patent also includes a pharmaceutical composition that utilizes the adult OPC produced through this method.
Career Highlights
Yasuhito Tokumoto is affiliated with the Japan Science and Technology Agency, where he conducts his research and development. His work focuses on innovative methods that can lead to breakthroughs in medical treatments and understanding of cellular processes.
Collaborations
He has collaborated with notable colleagues such as Makoto Suematsu and Shinpei Tamaki. These partnerships have contributed to the advancement of research in their respective fields.
Conclusion
Yasuhito Tokumoto's contributions to the field of cellular biology, particularly through his patented methods for producing oligodendrocyte progenitor cells, highlight his role as an innovator. His work has the potential to impact therapeutic approaches in neurobiology significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
